California veterans push for fast tracked research on psychedelic therapy to address the veteran suicide crisis, citing ibogaine results and AB 1103

Psychedelic therapy for veterans is gaining political momentum in California as advocates argue it can help reduce the veteran suicide crisis, backed by accounts from Special Forces veterans who tried ibogaine. The article describes Joe Hudak’s experience with an ibogaine treatment connected to a Stanford observational study, where he reports that intrusive anxiety and suicidal thoughts went “silent” after one dose. The story also cites reported symptom reductions among participants in the study. Nonprofit Veterans Exploring Treatment Solutions supports access to psychedelic therapy abroad and is now pushing for U.S.-based research. California’s advocacy centers on Assembly Bill 1103, intended to speed approval of academic studies involving Schedule I and II drugs by reducing regulatory delays through changes to the state’s Research Advisory Panel.